Singapore
32.1°C
Cloudy / 32.1°C
Sat / 29.8°C
Sun / 31.2°C
Mon / 31.5°C
am
7:55
All the News in one place from Singapore
More than 50 news sites, more than 1000 pieces of news daily
Revance Shares Jump 17% After FDA Approves Botox Rival
(September 09 03:35) Forbes.com
Revance Therapeutics says its new treatment, Daxxify, diminishes facial wrinkles for up to six months.
You can find the original article
here
Share Revance Shares Jump 17% After FDA Approves Botox Rival on your favourite social media
Facebook
Twitter
Google +